The Epidermal Transcriptome Analysis of a Novel c.639_642dup <i>LORICRIN</i> Variant-Delineation of the Loricrin Keratoderma Pathology

Loricrin keratoderma (LK) is a rare autosomal dominant genodermatosis caused by <i>LORICRIN</i> gene mutations. The pathogenesis of the disease is not yet fully understood. So far, only 10 pathogenic variants in <i>LORICRIN</i> have been described, with all of them but one be...

Full description

Bibliographic Details
Main Authors: Katarzyna Wertheim-Tysarowska, Katarzyna Osipowicz, Bartłomiej Gielniewski, Bartosz Wojtaś, Alicja Szabelska-Beręsewicz, Joanna Zyprych-Walczak, Adriana Mika, Andrzej Tysarowski, Katarzyna Duk, Agnieszka Magdalena Rygiel, Katarzyna Niepokój, Katarzyna Woźniak, Cezary Kowalewski, Jolanta Wierzba, Aleksandra Jezela-Stanek
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/11/9459
_version_ 1797597414531530752
author Katarzyna Wertheim-Tysarowska
Katarzyna Osipowicz
Bartłomiej Gielniewski
Bartosz Wojtaś
Alicja Szabelska-Beręsewicz
Joanna Zyprych-Walczak
Adriana Mika
Andrzej Tysarowski
Katarzyna Duk
Agnieszka Magdalena Rygiel
Katarzyna Niepokój
Katarzyna Woźniak
Cezary Kowalewski
Jolanta Wierzba
Aleksandra Jezela-Stanek
author_facet Katarzyna Wertheim-Tysarowska
Katarzyna Osipowicz
Bartłomiej Gielniewski
Bartosz Wojtaś
Alicja Szabelska-Beręsewicz
Joanna Zyprych-Walczak
Adriana Mika
Andrzej Tysarowski
Katarzyna Duk
Agnieszka Magdalena Rygiel
Katarzyna Niepokój
Katarzyna Woźniak
Cezary Kowalewski
Jolanta Wierzba
Aleksandra Jezela-Stanek
author_sort Katarzyna Wertheim-Tysarowska
collection DOAJ
description Loricrin keratoderma (LK) is a rare autosomal dominant genodermatosis caused by <i>LORICRIN</i> gene mutations. The pathogenesis of the disease is not yet fully understood. So far, only 10 pathogenic variants in <i>LORICRIN</i> have been described, with all of them but one being deletions or insertions. The significance of rare nonsense variants remains unclear. Furthermore, no data regarding the RNA expression in affected patients are available. The aim of this study is to describe the two variants in the <i>LORICRIN</i> gene found in two distinct families: the novel pathogenic variant c.639_642dup and a rare c.10C > T (p.Gln4Ter) of unknown significance. We also present the results of the transcriptome analysis of the lesional loricrin keratoderma epidermis of a patient with c.639_642dup. We show that in the LK lesion, the genes associated with epidermis development and keratocyte differentiation are upregulated, while genes engaged in cell adhesion, differentiation developmental processes, ion homeostasis and transport, signaling and cell communication are downregulated. In the context of the p.Gln4Ter clinical significance evaluation, we provide data indicating that <i>LORICRIN</i> haploinsufficiency has no skin consequences. Our results give further insight into the pathogenesis of LK, which may have therapeutic implications in the future and important significance in the context of genetic counseling.
first_indexed 2024-03-11T03:05:45Z
format Article
id doaj.art-80ddb96cbb854d26996472ff6ff7563e
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-11T03:05:45Z
publishDate 2023-05-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-80ddb96cbb854d26996472ff6ff7563e2023-11-18T07:59:18ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-05-012411945910.3390/ijms24119459The Epidermal Transcriptome Analysis of a Novel c.639_642dup <i>LORICRIN</i> Variant-Delineation of the Loricrin Keratoderma PathologyKatarzyna Wertheim-Tysarowska0Katarzyna Osipowicz1Bartłomiej Gielniewski2Bartosz Wojtaś3Alicja Szabelska-Beręsewicz4Joanna Zyprych-Walczak5Adriana Mika6Andrzej Tysarowski7Katarzyna Duk8Agnieszka Magdalena Rygiel9Katarzyna Niepokój10Katarzyna Woźniak11Cezary Kowalewski12Jolanta Wierzba13Aleksandra Jezela-Stanek14Department of Medical Genetics, Institute of Mother and Child, 01-211 Warsaw, PolandDepartment of Dermatology, Immunodermatology and Venereology, Medical University of Warsaw, 02-008 Warsaw, PolandLaboratory of Molecular Neurobiology, Nencki Institute of Experimental Biology, 02-093 Warsaw, PolandLaboratory of Molecular Neurobiology, Nencki Institute of Experimental Biology, 02-093 Warsaw, PolandDepartment of Mathematical and Statistical Methods, Poznań University of Life Sciences, 60-637 Poznań, PolandDepartment of Mathematical and Statistical Methods, Poznań University of Life Sciences, 60-637 Poznań, PolandDepartment of Pharmaceutical Biochemistry, Medical University of Gdansk, 80-211 Gdansk, PolandMolecular and Translational Oncology Department and Cancer Molecular and Genetic Diagnostics Department, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, PolandDepartment of Medical Genetics, Institute of Mother and Child, 01-211 Warsaw, PolandDepartment of Medical Genetics, Institute of Mother and Child, 01-211 Warsaw, PolandDepartment of Medical Genetics, Institute of Mother and Child, 01-211 Warsaw, PolandDepartment of Dermatology, Immunodermatology and Venereology, Medical University of Warsaw, 02-008 Warsaw, PolandDepartment of Dermatology, Immunodermatology and Venereology, Medical University of Warsaw, 02-008 Warsaw, PolandDepartment of Paediatrics, Haematology and Oncology, Department of General Nursery, Medical University of Gdansk, 80-211 Gdansk, PolandDepartment of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, 01-138 Warsaw, PolandLoricrin keratoderma (LK) is a rare autosomal dominant genodermatosis caused by <i>LORICRIN</i> gene mutations. The pathogenesis of the disease is not yet fully understood. So far, only 10 pathogenic variants in <i>LORICRIN</i> have been described, with all of them but one being deletions or insertions. The significance of rare nonsense variants remains unclear. Furthermore, no data regarding the RNA expression in affected patients are available. The aim of this study is to describe the two variants in the <i>LORICRIN</i> gene found in two distinct families: the novel pathogenic variant c.639_642dup and a rare c.10C > T (p.Gln4Ter) of unknown significance. We also present the results of the transcriptome analysis of the lesional loricrin keratoderma epidermis of a patient with c.639_642dup. We show that in the LK lesion, the genes associated with epidermis development and keratocyte differentiation are upregulated, while genes engaged in cell adhesion, differentiation developmental processes, ion homeostasis and transport, signaling and cell communication are downregulated. In the context of the p.Gln4Ter clinical significance evaluation, we provide data indicating that <i>LORICRIN</i> haploinsufficiency has no skin consequences. Our results give further insight into the pathogenesis of LK, which may have therapeutic implications in the future and important significance in the context of genetic counseling.https://www.mdpi.com/1422-0067/24/11/9459loricrinloricrin keratodermatranscriptomemutation
spellingShingle Katarzyna Wertheim-Tysarowska
Katarzyna Osipowicz
Bartłomiej Gielniewski
Bartosz Wojtaś
Alicja Szabelska-Beręsewicz
Joanna Zyprych-Walczak
Adriana Mika
Andrzej Tysarowski
Katarzyna Duk
Agnieszka Magdalena Rygiel
Katarzyna Niepokój
Katarzyna Woźniak
Cezary Kowalewski
Jolanta Wierzba
Aleksandra Jezela-Stanek
The Epidermal Transcriptome Analysis of a Novel c.639_642dup <i>LORICRIN</i> Variant-Delineation of the Loricrin Keratoderma Pathology
International Journal of Molecular Sciences
loricrin
loricrin keratoderma
transcriptome
mutation
title The Epidermal Transcriptome Analysis of a Novel c.639_642dup <i>LORICRIN</i> Variant-Delineation of the Loricrin Keratoderma Pathology
title_full The Epidermal Transcriptome Analysis of a Novel c.639_642dup <i>LORICRIN</i> Variant-Delineation of the Loricrin Keratoderma Pathology
title_fullStr The Epidermal Transcriptome Analysis of a Novel c.639_642dup <i>LORICRIN</i> Variant-Delineation of the Loricrin Keratoderma Pathology
title_full_unstemmed The Epidermal Transcriptome Analysis of a Novel c.639_642dup <i>LORICRIN</i> Variant-Delineation of the Loricrin Keratoderma Pathology
title_short The Epidermal Transcriptome Analysis of a Novel c.639_642dup <i>LORICRIN</i> Variant-Delineation of the Loricrin Keratoderma Pathology
title_sort epidermal transcriptome analysis of a novel c 639 642dup i loricrin i variant delineation of the loricrin keratoderma pathology
topic loricrin
loricrin keratoderma
transcriptome
mutation
url https://www.mdpi.com/1422-0067/24/11/9459
work_keys_str_mv AT katarzynawertheimtysarowska theepidermaltranscriptomeanalysisofanovelc639642dupiloricrinivariantdelineationoftheloricrinkeratodermapathology
AT katarzynaosipowicz theepidermaltranscriptomeanalysisofanovelc639642dupiloricrinivariantdelineationoftheloricrinkeratodermapathology
AT bartłomiejgielniewski theepidermaltranscriptomeanalysisofanovelc639642dupiloricrinivariantdelineationoftheloricrinkeratodermapathology
AT bartoszwojtas theepidermaltranscriptomeanalysisofanovelc639642dupiloricrinivariantdelineationoftheloricrinkeratodermapathology
AT alicjaszabelskaberesewicz theepidermaltranscriptomeanalysisofanovelc639642dupiloricrinivariantdelineationoftheloricrinkeratodermapathology
AT joannazyprychwalczak theepidermaltranscriptomeanalysisofanovelc639642dupiloricrinivariantdelineationoftheloricrinkeratodermapathology
AT adrianamika theepidermaltranscriptomeanalysisofanovelc639642dupiloricrinivariantdelineationoftheloricrinkeratodermapathology
AT andrzejtysarowski theepidermaltranscriptomeanalysisofanovelc639642dupiloricrinivariantdelineationoftheloricrinkeratodermapathology
AT katarzynaduk theepidermaltranscriptomeanalysisofanovelc639642dupiloricrinivariantdelineationoftheloricrinkeratodermapathology
AT agnieszkamagdalenarygiel theepidermaltranscriptomeanalysisofanovelc639642dupiloricrinivariantdelineationoftheloricrinkeratodermapathology
AT katarzynaniepokoj theepidermaltranscriptomeanalysisofanovelc639642dupiloricrinivariantdelineationoftheloricrinkeratodermapathology
AT katarzynawozniak theepidermaltranscriptomeanalysisofanovelc639642dupiloricrinivariantdelineationoftheloricrinkeratodermapathology
AT cezarykowalewski theepidermaltranscriptomeanalysisofanovelc639642dupiloricrinivariantdelineationoftheloricrinkeratodermapathology
AT jolantawierzba theepidermaltranscriptomeanalysisofanovelc639642dupiloricrinivariantdelineationoftheloricrinkeratodermapathology
AT aleksandrajezelastanek theepidermaltranscriptomeanalysisofanovelc639642dupiloricrinivariantdelineationoftheloricrinkeratodermapathology
AT katarzynawertheimtysarowska epidermaltranscriptomeanalysisofanovelc639642dupiloricrinivariantdelineationoftheloricrinkeratodermapathology
AT katarzynaosipowicz epidermaltranscriptomeanalysisofanovelc639642dupiloricrinivariantdelineationoftheloricrinkeratodermapathology
AT bartłomiejgielniewski epidermaltranscriptomeanalysisofanovelc639642dupiloricrinivariantdelineationoftheloricrinkeratodermapathology
AT bartoszwojtas epidermaltranscriptomeanalysisofanovelc639642dupiloricrinivariantdelineationoftheloricrinkeratodermapathology
AT alicjaszabelskaberesewicz epidermaltranscriptomeanalysisofanovelc639642dupiloricrinivariantdelineationoftheloricrinkeratodermapathology
AT joannazyprychwalczak epidermaltranscriptomeanalysisofanovelc639642dupiloricrinivariantdelineationoftheloricrinkeratodermapathology
AT adrianamika epidermaltranscriptomeanalysisofanovelc639642dupiloricrinivariantdelineationoftheloricrinkeratodermapathology
AT andrzejtysarowski epidermaltranscriptomeanalysisofanovelc639642dupiloricrinivariantdelineationoftheloricrinkeratodermapathology
AT katarzynaduk epidermaltranscriptomeanalysisofanovelc639642dupiloricrinivariantdelineationoftheloricrinkeratodermapathology
AT agnieszkamagdalenarygiel epidermaltranscriptomeanalysisofanovelc639642dupiloricrinivariantdelineationoftheloricrinkeratodermapathology
AT katarzynaniepokoj epidermaltranscriptomeanalysisofanovelc639642dupiloricrinivariantdelineationoftheloricrinkeratodermapathology
AT katarzynawozniak epidermaltranscriptomeanalysisofanovelc639642dupiloricrinivariantdelineationoftheloricrinkeratodermapathology
AT cezarykowalewski epidermaltranscriptomeanalysisofanovelc639642dupiloricrinivariantdelineationoftheloricrinkeratodermapathology
AT jolantawierzba epidermaltranscriptomeanalysisofanovelc639642dupiloricrinivariantdelineationoftheloricrinkeratodermapathology
AT aleksandrajezelastanek epidermaltranscriptomeanalysisofanovelc639642dupiloricrinivariantdelineationoftheloricrinkeratodermapathology